Gallstone Disease and the Risk of Cardiovascular Disease

Cameron J Fairfield1, Stephen J Wigmore2, Ewen M Harrison2

  • 1Department of Clinical Surgery, The University of Edinburgh, Edinburgh, EH16 4SA, UK. cameron.fairfield@ed.ac.uk.

Scientific Reports
|April 11, 2019
PubMed

Insights

Gallstone disease (GD) is linked to a higher risk of cardiovascular disease (CVD) events. This meta-analysis of over 1.2 million people confirms a significant association between gallstones and CVD in both sexes.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Epidemiology

Background:

  • Gallstone disease (GD) is a common surgical condition.
  • Cardiovascular disease (CVD) is a leading cause of mortality and economic burden.
  • Shared risk factors exist between GD and CVD.

Purpose of the Study:

  • To conduct a meta-analysis assessing the relationship between gallstone disease and cardiovascular disease.
  • To evaluate the association between gallstone disease and fatal/non-fatal CVD events.
  • To explore the impact of cholecystectomy on the GD-CVD association.

Main Methods:

  • Meta-analysis of fourteen cohort studies.
  • Inclusion of over 1.2 million participants.
  • Random-effects model to calculate pooled hazard ratios (HR) and 95% confidence intervals (CI).

Main Results:

  • A significant association was found between gallstone disease and fatal/non-fatal CVD events (HR: 1.23, 95% CI: 1.16-1.30).
  • This association was observed in both females and males.
  • Cholecystectomy showed a potentially stronger association with CVD (HR: 1.41, 95% CI: 1.21-1.64) compared to GD without surgery (HR: 1.30, 95% CI: 1.07-1.58), though confounding is noted.

Conclusions:

  • Gallstone disease is significantly associated with an increased risk of cardiovascular disease events.
  • The association between gallstone disease and cardiovascular disease is present in both sexes.
  • Further research is required to clarify the influence of cholecystectomy on this association.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
453
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
488
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
854